Literature DB >> 18849606

Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).

Y Chaves, G Duarte, B Ben-Said, J Tebib, F Berard, J F Nicolas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849606     DOI: 10.1159/000162180

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  6 in total

Review 1.  Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Authors:  Isabelle Cleynen; Séverine Vermeire
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 2.  Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.

Authors:  Ralph M Trüeb; Maria Fernanda Reis Gavazzoni Dias
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  A mouse model of clonal CD8+ T lymphocyte-mediated alopecia areata progressing to alopecia universalis.

Authors:  Rajshekhar Alli; Phuong Nguyen; Kelli Boyd; John P Sundberg; Terrence L Geiger
Journal:  J Immunol       Date:  2011-11-23       Impact factor: 5.422

Review 4.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

5.  Alopecia areata: a new treatment plan.

Authors:  Adel Alsantali
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-07-22

6.  Detection of Tumor Necrosis Factor-alpha in Nonlesional Tissues of Alopecia Areata Patients: A Prove for a Systemic Disease.

Authors:  Yasser Mostsfa Gohary; Dina Sabry Abdel Fattah
Journal:  Int J Trichology       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.